BOONE; Thomas Charles
Patent Applications and Registrations
Patent applications and USPTO patent grants for BOONE; Thomas Charles.The latest application filed is for "stabilized receptor polypeptides and uses thereof".
Company Profile
5.13.38
- BOONE; Thomas Charles - Newbury Park CA
Patent Activity
| Patent | Date |
|---|---|
| Stabilized Receptor Polypeptides And Uses Thereof App 20200283504 - SUN; Jeonghoon ; et al. | 2020-09-10 |
| Stabilized Receptor Polypeptides And Uses Thereof App 20190389932 - SUN; Jeonghoon ; et al. | 2019-12-26 |
| Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof Grant 10,336,820 - Boone , et al. | 2019-07-02 |
| Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereof Grant 10,308,704 - Sun , et al. | 2019-06-04 |
| Carrier immunoglobulins Grant 10,189,912 - Walker , et al. Ja | 2019-01-29 |
| Carrier Immunoglobulins App 20170190793 - WALKER; Kenneth W. ; et al. | 2017-07-06 |
| Stabilized Receptor Polypeptides and Uses Thereof App 20170183391 - Sun; Jeonghoon ; et al. | 2017-06-29 |
| Antibodies Directed To Angiopoietin-1 And Angiopoietin-2 And Uses Thereof App 20170081398 - Boone; Thomas Charles ; et al. | 2017-03-23 |
| Carrier immunoglobulins Grant 9,562,108 - Walker , et al. February 7, 2 | 2017-02-07 |
| Carrier immunoglobulins Grant 9,562,107 - Walker , et al. February 7, 2 | 2017-02-07 |
| Stabilized Receptor Polypeptides and Uses Thereof App 20160137718 - Sun; Jeonghoon ; et al. | 2016-05-19 |
| Myostatin Binding Agents App 20150175687 - Han; Huiquan ; et al. | 2015-06-25 |
| Carrier Immunoglobulins App 20150044236 - WALKER; Kenneth W. ; et al. | 2015-02-12 |
| Carrier Immunoglobulins App 20150044235 - WALKER; Kenneth W. ; et al. | 2015-02-12 |
| Myostatin binding agents, nucleic acids encoding the same, and methods of treatment Grant 8,920,798 - Han , et al. December 30, 2 | 2014-12-30 |
| Hepcidin, Hepcidin Antagonists And Methods Of Use App 20140286953 - Sasu; Barbra ; et al. | 2014-09-25 |
| Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof App 20140273089 - Saris; Christiaan M. ; et al. | 2014-09-18 |
| Hepcidin, hepcidin antagonists and methods of use Grant 8,629,250 - Sasu , et al. January 14, 2 | 2014-01-14 |
| Antibodies Directed To Angiopoietin-1 And Angiopoietin-2 And Uses Thereof App 20130336992 - Boone; Thomas Charles ; et al. | 2013-12-19 |
| Myostatin Binding Agents App 20130230515 - HAN; HQ ; et al. | 2013-09-05 |
| Myostatin Binding Agents App 20120083442 - HAN; HQ ; et al. | 2012-04-05 |
| Myostatin binding agents App 20100330072 - Han; HQ ; et al. | 2010-12-30 |
| Myostatin binding agents App 20090227517 - Han; Hq ; et al. | 2009-09-10 |
| Binding agents which inhibit myostatin App 20090220491 - Han; Hq ; et al. | 2009-09-03 |
| Myostatin binding agents Grant 7,511,012 - Han , et al. March 31, 2 | 2009-03-31 |
| Modified peptides as therapeutic agents Grant 7,488,590 - Feige , et al. February 10, 2 | 2009-02-10 |
| Hepcidin, Hepcidin Antagonists And Methods Of Use App 20080213277 - Sasu; Barbra ; et al. | 2008-09-04 |
| Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof Grant 7,348,162 - Saris , et al. March 25, 2 | 2008-03-25 |
| Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof App 20080044859 - Saris; Christiaan M. ; et al. | 2008-02-21 |
| Modified peptides as therapeutic agents App 20070049532 - Feige; Ulrich ; et al. | 2007-03-01 |
| VGF fusion polypeptides App 20070010662 - Yan; Hai ; et al. | 2007-01-11 |
| Modified peptides as therapeutic agents App 20060234307 - Feige; Ulrich ; et al. | 2006-10-19 |
| VGF fusion polypeptides Grant 7,008,924 - Yan , et al. March 7, 2 | 2006-03-07 |
| Analogs of cationic proteins App 20050143294 - Boone, Thomas Charles ; et al. | 2005-06-30 |
| Modified peptides as therapeutic agents App 20050123548 - Feige, Ulrich ; et al. | 2005-06-09 |
| VGF polypeptides and methods of treating VGF-related disorders App 20050049180 - Yan, Hai ; et al. | 2005-03-03 |
| Binding agents which inhibit myostatin App 20040181033 - Han, Hq ; et al. | 2004-09-16 |
| Modified peptides as therapeutic agents App 20040087778 - Feige, Ulrich ; et al. | 2004-05-06 |
| Modified peptides as therapeutic agents App 20040077022 - Feige, Ulrich ; et al. | 2004-04-22 |
| Protein analogs of brain-derived neurotrophic factor Grant 6,723,701 - Boone , et al. April 20, 2 | 2004-04-20 |
| Modified peptides as therapeutic agents App 20040071712 - Feige, Ulrich ; et al. | 2004-04-15 |
| Modified peptides as therapeutic agents App 20040057953 - Feige, Ulrich ; et al. | 2004-03-25 |
| Modified peptides as therapeutic agents App 20040053845 - Feige, Ulrich ; et al. | 2004-03-18 |
| Modified peptides as therapeutic agents App 20040044188 - Feige, Ulrich ; et al. | 2004-03-04 |
| Fibroblast growth factor receptor-like molecules and uses thereof App 20030087384 - Saris, Christiaan M. ; et al. | 2003-05-08 |
| Substitution analogs of NT-3 App 20020052488 - Boone, Thomas Charles ; et al. | 2002-05-02 |
| Analogs of cationic proteins App 20020010135 - Boone, Thomas Charles ; et al. | 2002-01-24 |
| Fibroblast growth factor receptor-like molecules and uses thereof App 20020009776 - Saris, Christiaan M. ; et al. | 2002-01-24 |
| Antibodies against analogs of brain-derived neurotrophic factor App 20010027179 - Boone, Thomas Charles ; et al. | 2001-10-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 